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Abstract
The relatively high cost of delivering many public health interventions limits their potential for 
broad public impact by reducing their likelihood of adoption and maintenance over time. 
Practitioners identify cost as the primary factor for which interventions they select to implement, 
but researchers rarely disseminate cost information or consider its importance when developing 
new interventions. A new approach is proposed, whereby intervention developers assess what 
individuals and agencies adopting their interventions are willing to pay and then design 
interventions that are responsive to this price range. The ultimate goal is to develop effective and 
affordable interventions, called lean interventions, which are widely adopted and have greater 
public health impact.
Introduction
Public health practitioners have been slow to adopt evidence– based prevention 
interventions (EBIs).1,2 To help address this problem, a growing number of scholars 
advocate applying lessons from the marketing and business literature.3–6 The private sector 
has developed a number of sophisticated approaches for pricing and developing products 
that researchers might apply to interventions to promote their adoption. The purpose of this 
paper is to (1) describe the role of cost as a barrier to adoption of EBIs; (2) detail approaches 
the private sector uses to understand consumer willingness to pay for products; and (3) 
recommend ways that intervention developers can apply these approaches to design 
interventions that are both efficacious and affordable.
Role of Cost in Public Health Interventions
An EBI's potential to improve health is determined not only by its efficacy but also by the 
extent to which it is adopted and implemented in practice.7 To ensure adoption and 
implementation, interventions need to be designed with the needs and constraints of 
practitioners and settings in mind.8 Although both researchers and practitioners place a high 
priority on intervention efficacy, researchers often give less attention to other factors that are 
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important to practitioners. With the goal of achieving large effect sizes, researchers have 
created complex, costly interventions that are not affordable in practice.9 Although the focus 
on efficacy may be central to the discovery stage of the research continuum, as researchers 
progress to studies of effectiveness, they also need to consider factors such as cost, which 
are critical to ensuring broad-scale adoption and implementation.10,11
The costs of delivering interventions include the price of purchasing the program, if there is 
such a cost, and also the costs of supplies, equipment, space, and staff time. Some of these 
costs such as equipment and supplies translate into line-item costs in an agency's budget. 
Other costs, such as staff time and space, often represent opportunity costs––resources 
diverted from delivering different EBIs or performing other activities related to the 
organization's mission.
Failing to create interventions that target organizations can afford may be a central 
contributor to the underuse of EBIs in practice.10,12–14 In numerous studies, public health 
and other decision makers have identified the high cost and resource intensity of 
interventions as one of the primary barriers to their use.15,16 In one study, state–level public 
health practitioners ranked availability of adequate resources as the top priority in selecting 
interventions, with evidence of scientific effectiveness as the second highest.17
An EBI's cost not only affects its potential for widespread adoption but also organizations' 
ability to implement the intervention with fidelity and maintain it over time.7,18,19 It is 
remarkable that practitioners identify cost as a central criterion for selecting EBIs, yet 
researchers rarely measure cost and almost never query their potential customers about the 
affordability of interventions they are developing. To promote greater adoption of 
interventions, researchers must become savvier about assessing intervention costs, 
understanding what organizations adopting these interventions are willing to pay, and 
keeping interventions affordable. Lean manufacturing is utilized in the business world, 
where manufacturers consider customer value, eliminate processes that do not add value to 
their business, and create more efficiency in their operation.20 There is a growing movement 
in healthcare to adopt “lean thinking” to control costs and improve quality.21,22 Public 
health organizations face funding constraints that require similar approaches to make better 
use of available funding, necessitating a movement toward lean interventions.
Current Use of Cost Information in Intervention Development
When researchers do report on costs, they most frequently report the findings of cost 
effectiveness analyses (CEA) as opposed to costs adopting organizations incurred delivering 
the intervention. A well-done CEA compares interventions to identify those that yield the 
greatest unit of benefit per unit of cost or, in other words, the biggest “bang for the buck.” 
Many CEAs are conducted from the perspective of society or a third-party payer, as opposed 
to the perspective of the implementing organization.23 Analyses performed from a societal 
or third-party perspective typically include costs incurred over an extended period of time 
and may report an intervention's cost effectiveness in relation to the widely accepted 
willingness to pay threshold of $50,000 per quality adjusted life year (QALY) saved. 
Although this perspective may be relevant for some customers, such as those making 
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decisions about what Medicare will cover, most customers want answers to a different 
question. They want to know what an intervention will cost their organization over the short 
term so they can assess whether it can be implemented within the constraints of their 
practice setting.24,25 When researchers do estimate an organization's actual costs to 
implement an intervention, they rarely do sensitivity analyses to assess variations in costs 
that occur when interventions are delivered in different settings or formats.26 To promote the 
adoption of EBIs in practice, researchers need to specify the full costs of implementing an 
intervention and develop a greater understanding of the price that organizations are willing 
to pay to implement the EBI. In the business world, venture capitalists or other investors 
ask, Will the dogs eat the dog food? to indicate whether the product will sell at the 
recommended retail price. Similarly, considering the full price of an EBI, researchers should 
be asking, Are we offering something that organizations want and can reasonably afford to 
buy?
Researchers often conduct extensive formative research on the target audience and rely upon 
formal program planning models to identify and meticulously shape intervention 
components. However, they rarely build “ability to afford” assessments into this early phase. 
Thus, the current practice is comparable to an architect designing a house for a couple and 
asking them whether they would like various features such as a gourmet kitchen, wine 
cellar, patio, swimming pool, and detached three-car garage––without ever asking them 
about their construction budget. It is easy to design a house that the homeowners will love if 
there are no cost constraints, but that does not reflect reality for most homebuyers. To 
promote EBI adoption, evidence on what is efficacious needs to be balanced with evidence 
on what organizations are willing to pay. In other words, an approach is needed that helps 
strike the proper balance between the “wish list” and the “wallet.”
Lessons from the Marketing and Business Literature
Recognizing the need to balance EBI costs with adopters' budgets, the key question is, What 
is the best way to do this? These are challenges faced every day by businesses around the 
world as they develop products with the goal of neither overcharging nor undercharging 
consumers. If they overcharge consumers, they will have low sales and a high inventory. If 
they undercharge, they will have left potential profit on the table. In response to this 
challenge, businesses have developed a number of marketing approaches to identifying who 
makes the decision to use the product (the customers) and the types of products they need 
and want.27 We suspect that many, if not the majority, of currently available interventions 
are not affordable to end users. A company that perennially creates overpriced products will 
eventually go out of business. However, researchers creating health behavior change 
interventions that have high efficacy, but are too costly to be viable in the real world, often 
have great success in securing grants, publishing their findings, and advancing in their 
fields, regardless of whether practitioners actually adopt their overpriced interventions.
Pricing from a Business Perspective
Businesses set prices by focusing on the product or the customers.28 In the product-led 
approach, engineering and manufacturing departments design and build what they think is a 
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superior product because of its advanced technology or capability. Nagle and colleagues28 
describe an example of a company that built very durable, high–quality office furniture that 
could last for 20 years, but nevertheless had low market share. The company was not 
successful at selling its product because, although durability is a desirable quality in a piece 
of furniture, it is not what consumers in their target market valued. Their consumers were 
start-up companies that hoped to be acquired in the near future, and cared more about the 
short–term balance sheet than owning long-lasting furniture. In the product-led model, 
product development leads to a certain cost, which leads to a price, and consumers purchase 
the product if they value it enough to pay the price (Figure 1). Nagle et al.28 argue that this 
approach is problematic because of the potential for consumers to undervalue and therefore 
under-purchase the product, resulting in wasted resources and low impact on the consumer 
market. However, this is the approach taken by most intervention researchers who develop 
their intervention products, disseminate them without regard to price, and then wait for 
consumers (e.g., public health decision makers) to decide whether or not to expend the 
resources required to implement the intervention.
The alternate, customer-led approach reverses this process.28 It starts with customers and an 
understanding of the value they place on the features of a product, which are used to set a 
price, and then the product is designed with these parameters in mind. Nagle and 
colleagues28 note that the goal is then to only make products that are profitable given their 
value to the target consumers. Thus, the company develops many promising product ideas, 
but then scraps ideas for which the price a consumer is willing to pay is low because of the 
perceived value of the product. Researchers who apply this customer-led approach would 
spend more time during the formative stage of intervention development to better 
understand (1) the value of interventions to individuals or organizations adopting them and 
(2) the price they are willing to pay. Researchers then would develop interventions that fit 
the organizations' budgets.
The business literature describes several approaches to understanding what people will pay 
for goods and services. Private sector methods to determine price include cost-plus, 
competition-driven, and value-based pricing.28 Cost-plus, or cost-based, pricing is the most 
common and simple form of pricing. Using this strategy, prices are set based on the cost of 
the product, plus some percentage of the cost that serves as the profit. However, this strategy 
does not reflect consumer demand and can lead to overpricing when demand is low and 
underpricing when demand is high. Competition-driven, or share-driven, pricing involves 
consideration of competitors' prices to set the price of one's own product. This generally 
involves lowering the price of the product to meet the market share price, even though its 
value could exceed the value of others' products.
A more strategic method, value-based pricing, starts with customers to determine the value 
they place on a product, and subsequently prices the product according to value.28 Unlike 
businesses, which set prices to maximize revenue and profits, researchers want to increase 
intervention impact by maximizing reach and adoption. Although a company might not care 
if the number of customers is very low as long as profit margins are high (called skim 
pricing in the business literature), a public health researcher would worry about this low 
population reach because it is unlikely to move the needle on population health.
Ribisl et al. Page 4













An example of a customer-led approach that utilizes value-based pricing is the Kickstarter 
initiative (kickstarter.com). Kickstarter employs crowdfunding, a type of crowdsourcing that 
involves recruiting backers to fund mostly small-scale, promising, innovative projects within 
a specified period of time.29 Through this method, product developers gauge potential 
consumers' interest in the product and only pursue projects if they meet their fundraising 
goal. Like EBI developers, product developers using the Kickstarter platform have already 
generated ideas and planned for implementation, and are ready to make their work available 
to those who will use it. For example, Air Quality Egg is a product that a community of 
designers launched on Kickstarter that assesses air quality in the vicinity of one's home and 
allows the user to share the data captured with others on the web (kickstarter.com/projects/
edborden/air-quality-egg). This project has exceeded its fundraising goal of $39,000 by 
$105,592 since it launched in March of 2012. Although some comments from backers were 
critical of the concept, it is clear that many people highly valued the mission of the product 
and the capability of the developers to create a quality product. When comparing this to 
intervention development, determining if decision makers believe that an intervention is 
worthwhile and feasible given the amount of money available can increase the intervention's 
viability and likelihood of adoption. The website quirky.com has a similar process to vet 
new product ideas. The first step is a product evaluation where the concept is described and 
critiqued. Engineering is the next step when the product must be able to be successfully 
prototyped. Once the product passes the evaluation and engineering phases, quirky.com 
visitors participate in a pricing exercise that determines how much they would pay, and if 
the gap between the perceived value and production cost is too large, the product is 
stalled.30
Price Sensitivity and Willingness to Pay
Businesses assess both price sensitivity and willingness to pay to determine the viability of 
new products and their pricing. Price sensitivity is a market's responsiveness to a change in 
price, with a large response indicating a sensitive market, and a small response an 
insensitive market.31 Although there are a variety of methods to assess price sensitivity, the 
most common involves surveying consumers of a particular product on their preferences and 
intentions.28 Survey methods have advantages over other methods such as experimental 
approaches or real-world field tests, where the product is offered at various price points and 
resulting sales are tallied. Survey methods are much cheaper, offer rapid results, and can be 
tested before a product is designed.28 Buy–response survey methods aim to capture a 
consumer's willingness to pay for a product. Businesses rarely ask consumers an open-ended 
question such as, How much would you pay for this product? Instead, they describe the 
product and sometimes randomize consumers to view three to five different prices. 
Responses are reported on a scale of likelihood of purchase or by category of purchase 
intention. Responses are then converted into estimates of the number of people for each 
response category who would actually purchase that product. These estimates can be used to 
predict the total number of products purchased and how much revenue will be generated for 
various price points.
Figure 2 displays the results of a buy-response survey comparing two different interventions 
priced between $250 and $1000. Intervention A remains fairly popular among potential 
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buyers at all of the price points, and demand decreases linearly and fairly gradually with 
each higher price. Intervention B is less popular at all price points than Intervention A, and 
demand decreases dramatically when it is priced above $500. This tells potential 
intervention developers that they can price Intervention A at multiple levels and still 
anticipate strong demand, whereas Intervention B should be priced at $500 or less if they 
want it to be adopted widely. In addition, if they would only offer one intervention, 
Intervention A would be the better choice. Conducting buy-response surveys such as these 
would be a useful approach for EBIs because it would allow researchers to determine what 
price range would be acceptable to different subgroups of decision makers. Researchers then 
could potentially create a variety of customized packages/bundles of EBI components 
matched to the prices that different customers are willing to pay.6 Large private companies 
might be able to afford EBIs with more features than a local health department, for instance. 
The private company may want a worksite health–promotion program involving 
measurement of height and weight, blood draws for testing lipids, and one-on-one risk factor 
counseling. In contrast, the health department might prefer an online risk assessment with 
self-reported height and weight and tailored messages based on self-reported risk factors. 
Finally, the buy-response example focuses on a dollar cost, but could also be adapted to 
describe varying amounts of staffing resources needed to deliver and sustain an intervention.
In addition to surveying decision makers on willingness to pay, researchers should 
prospectively collect cost data during intervention development to make this information 
transparent to potential adopters. O'Connell and Griffin32 suggest conducting a cost analysis 
to capture all economic costs required to deliver an intervention, also referred to as micro-
costing. Understanding the costs associated with different intervention components can 
better equip researchers to predict and apply decision makers' willingness to pay and do a 
better job of pricing interventions for what real-world customers can afford. In addition, 
having cost information helps the customer in their efforts to make a case for the 
intervention's return on investment to higher–level decision makers. Table 1 provides a 
summary of existing challenges and recommendations to guide researchers in addressing 
cost in their intervention development.
Diabetes Self-Management Example
Diabetes self-management (DSM) interventions provide an example of how researchers 
might use value–based pricing strategies to increase adoption. Many researcher–developed 
DSM interventions involve multiple in-person contacts over extended periods of time. The 
resources required to implement these interventions are a poor fit with the settings that 
provide diabetes care.9
If the goal is to improve DSM, then researchers need to rethink their approach to designing 
interventions to increase their adoption in practice. Researchers first need to identify the 
agencies and organizations that provide care to individuals with diabetes, particularly those 
with the greatest need, that is, their potential customers. Potential customers may include, 
for example, health departments, Federally Qualified Health Centers, health insurers, disease 
management organizations, or physician practices. They then need to identify the individuals 
within these organizations who are responsible for making the decision to adopt new 
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programs. Researchers would then survey representative decision makers from one or more 
targeted organizations to identify the amount they are willing to pay for specific DSM 
interventions and factors that influence the amount they are willing to pay, such as evidence 
supporting intervention effects.33,34 Surveys may present a menu of DSM interventions with 
various resource requirements and ask respondents to assess their affordability on a Likert 
scale with interventions varying on mode of delivery, type and number of involved 
professionals, included materials, and number of contacts.
For organizations that account for per-unit costs such as health insurers and disease 
management organizations, surveys could involve direct questions about the amount 
organizations are willing to pay per client/patient. For other organizations, the survey may 
need to get at costs less directly by asking about the resources expended for existing disease 
management programs. Researchers could use findings from these surveys to design 
interventions that better fit the price their customers will pay. Researchers may design an 
intervention for a single type of customer or may customize it to fit the resources of different 
customers. For example, they might design a DSM intervention for health departments that a 
health educator could deliver through six group sessions and educational materials. They 
might package the same content in a format that a physician's office could use that would 
include these components plus a personal DSM coach and access to tailored materials on a 
website.
Conclusions
The current approach to developing EBIs favors the development of high-efficacy and high-
cost programs. Unfortunately, many organizations cannot afford to pay for these complex 
and intensive interventions. Therefore, many EBIs are not adopted as widely as they could 
be. Fortunately, the business literature contains pricing approaches that can be used to 
survey the person who is deciding to adopt or purchase the intervention or program. Even 
before the intervention is fully developed, the decision maker is presented with several 
programs at specific prices and asked to indicate their interest. We are not aware of anyone 
using these approaches to develop EBIs but believe they have potential, especially given 
recent calls in the literature for applying lessons from the marketing and business 
literature.3–6 Willingness to pay and cost data should be published to fuel the development 
of more realistic and scalable interventions. Researchers will likely be astonished at meager 
real–world intervention budgets, which could trigger the development of lean interventions 
that conform to the limited budgets of many health organizations.
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Figure 1. Alternative approaches to value creation
Adapted from O'Connell JM, Griffin S. Overview of methods in economic analyses of 
behavioral interventions to promote oral health. J Public Health Dent 2011;71(1S):S101–
S118.
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Figure 2. Purchase probability curve
Adapted from O'Connell JM, Griffin S. Overview of methods in economic analyses of 
behavioral interventions to promote oral health. J Public Health Dent 2011;71(1S):S101–
S118.
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Table 1
Status quo and proposed solution for fixing the disconnect between practitioners and 
intervention developers
Practitioners
Status quo Proposed solution for researchers
Have limited budgets, staffing, and other resources Engage in customer research to identify the resources available to 
practitioners and their willingness to pay for EBIs3
Must accommodate to varying priorities, budgets, and staffing 
levels
Provide a pool of EBIs that vary in cost and resource requirements4
Need EBIs that are easy to adapt to the local context and 
implement in practice
Design EBIs to be lean and maximize reach
Need to know the costs of using an EBI Collect data on the costs of adapting, implementing, and delivering EBIs24
Intervention developers/researchers
Status quo Proposed solution for academic institutions/funders
Are rewarded with publications, grants, and promotions for 
developing maximally effective EBIs regardless of EBI cost, 
staffing resources, or implementation feasibility
Reward based on work contributing to all phases of the research spectrum: 
initial discovery, refinement, further development, and delivery to practice7
Have few incentives to develop EBIs that meet practitioner 
needs and become widely adopted
Give priority to proposals that design interventions with scalability in 
mind8,33
Have limited information about practitioners' resource 
constraints
Fund customer research5 to understand end user budgets and resources, 
including buy-response studies
EBI, evidence-based intervention
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